Insider · CIK 0001927648
Erin Burkhart
Files at GILD (GILEAD SCIENCES, INC.), BMRN (BIOMARIN PHARMACEUTICAL INC). First filing Feb 25, 2025, latest May 20, 2025.
In brief
Erin Burkhart files SEC Form 4 as officer at BMRN (BIOMARIN PHARMACEUTICAL INC), and also at GILD (GILEAD SCIENCES, INC.). Since Feb 25, 2025, Erin Burkhart has reported 0 open-market buys worth $0 and 3 open-market sells worth $290k, the latest filed on May 20, 2025.
A track record needs three past buys with six months of prices behind them; Erin Burkhart has 0, so none is measured yet.
The newest scored trade: sold $106k of BMRN on May 20, 2025, filed May 20, 2025, scored 10 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BMRN: BIOMARIN PHARMACEUTICAL INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | BIOMARIN PHARMACEUTICAL INC | $106k 1,786 shares | -11% | +7% from low-29% from high | |
| 13Weak | BIOMARIN PHARMACEUTICAL INC | $93k 1,295 shares | -7% | - | |
| 12Weak | BIOMARIN PHARMACEUTICAL INC | $92k 1,344 shares | -9% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | 1,786 0.00% of outstanding | $106k | May 20, 2025 | $185k |
| Mar 19, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | 1,295 0.00% of outstanding | $93k | Mar 19, 2025 | $92k |
| Feb 24, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | 1,344 0.00% of outstanding | $92k | Feb 24, 2025 | none |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | GILD GILEAD SCIENCES, INC. | MOption exercise Common Stock | +2,223 | - | - | 2,223 | 20 d ago |
| Sep 22, 2026 | GILD GILEAD SCIENCES, INC. | FTax withholding Common Stock | -768 | $152.67 | $117k | 1,455 | 20 d ago |
| Sep 22, 2026 | GILD GILEAD SCIENCES, INC. | MOption exercise Restricted Stock Unitderivative | -2,223 | - | - | 9,022 | 20 d ago |
| Mar 10, 2026 | GILD GILEAD SCIENCES, INC. | AGrant or award Restricted Stock Unitderivative | +2,355 | - | - | 11,245 | Mar 12, 2026 |
| Mar 10, 2026 | GILD GILEAD SCIENCES, INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +5,455 | $0.00 | $0 | 5,455 | Mar 12, 2026 |
| Sep 22, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Restricted Stock Unitderivative | +8,890 | - | - | 8,890 | Sep 23, 2025 |
| May 19, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock10b5-1 | -996 | $59.27 | $59k | 15,959 | May 20, 2025 |
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | SOpen-market sale Common Stock10b5-1 | -1,786 | $59.31 | $106k | 14,173 | May 20, 2025 |
| Mar 19, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | SOpen-market sale Common Stock10b5-1 | -1,295 | $71.52 | $93k | 16,955 | Mar 20, 2025 |
| Mar 14, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -823 | $69.44 | $57k | 12,282 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +5,970 | $0.00 | $0 | 18,252 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +9,230 | $0.00 | $0 | 9,230 | Mar 18, 2025 |
| Feb 24, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | SOpen-market sale Common Stock10b5-1 | -1,344 | $68.38 | $92k | 13,105 | Feb 25, 2025 |
| Mar 15, 2024 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +4,720 | $0.00 | $0 | 18,814 | Mar 19, 2024 |
| Mar 18, 2024 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -372 | $83.87 | $31k | 18,442 | Mar 19, 2024 |
| Mar 15, 2024 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +7,050 | $0.00 | $0 | 7,050 | Mar 19, 2024 |
Questions about Erin Burkhart
Answered from the filings on this page, as of the latest one.
Is Erin Burkhart buying or selling?
Not in the last 12 months. Erin Burkhart's latest open-market trade on SEC Form 4 was sold $106k of BMRN on May 20, 2025.
How did Erin Burkhart's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Erin Burkhart has 0.
Where does Erin Burkhart file Form 4?
Erin Burkhart has filed Form 4 at BMRN (BIOMARIN PHARMACEUTICAL INC) as GVP, Chief Accounting Officer; GILD (GILEAD SCIENCES, INC.) as SVP, Controllership. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.